-
Dogecoin Technical Indicators Signal 'Buy' As Musk Suggests Tesla May Soon Accept DOGE Payments — Analyst Says 'Extreme Resistance Breakout Soon'
Thursday, March 14, 2024 - 7:00am | 463A pseudonymous analyst Vibranium Capital said that Dogecoin (CRYPTO: DOGE) is currently on a rally after overcoming some resistance levels. What Happened: The analyst in a post on TradingView said, “We got the breakout, resistance turned support, and now are heading for an extreme resistance...
-
Johnson & Johnson Set To Resume COVID-19 Vaccine Rollout In Europe — With A Warning On The Label
Wednesday, April 21, 2021 - 2:06am | 562Johnson & Johnson (NYSE: JNJ) said Tuesday that the European rollout of its COVID-19 vaccine is set to continue after it got the go-ahead from the regulator on the continent. What Happened: The multinational pharmaceutical giant said in a statement that the European Medical Agency’s...
-
PTC Therapeutics Surges 88% On European Marketing Authorization
Friday, November 11, 2016 - 9:46am | 362Shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) soared higher by nearly 90 percent early Friday morning after the company announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the renewal of the company's therapy called...
-
3 Pharma Companies Receive Positive EU Opinions
Friday, September 16, 2016 - 10:07am | 415Pfizer Inc. (NYSE: PFE), Amgen, Inc. (NASDAQ: AMGN) and Eli Lilly and Co (NYSE: LLY) received favorable opinions from the European Medicines Agency in response to their respective applications. Pfizer's IBRANCE® Pfizer disclosed that the European Medicines Agency (EMA)'s Committee for Medicinal...
-
Why NICE Recommendation Is Turning Point For PTC Therapeutics Shares
Monday, April 18, 2016 - 1:30pm | 414Oppenheimer said the recent recommendation from NICE for Translarna is a "turning point" for PTC Therapeutics, Inc. (NASDAQ: PTCT) shares, as it bodes well for the upcoming CHMP review. The Importance Of Translarna To PTC On Friday, shares of PTC Therapeutics surged more than 40 percent after it...
-
Leerink Comments On Orexigen Therapeutics, Says Current Projections Could Prove To Be 'Conservative'
Wednesday, March 4, 2015 - 1:01pm | 110In a report published Wednesday, Leerink analyst Paul Matteis commented on Orexigen Therapeutics, Inc. (NASDAQ: OREX) and wrote that following a positive opinion from the CHMP, the company expects a final opinion from the EMA on the Mysimba (Contrave) marketing authorization application. Matteis...
-
Market Wrap For February 21: Markets End The Week On A Negative Note
Friday, February 21, 2014 - 5:48pm | 2876U.S. stocks finished the week slightly lower as investors gave today's poor housing data a slack, and blame it on the weather. “Investors are willing to cut the market some slack because of the weather; I'm keeping my fingers crossed that the economy heats up as the weather warms up,” Jack...